These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 11261299)

  • 1. [Cell cycle and breast cancer].
    Puisieux A
    Ann Pathol; 2000; 20 Suppl():S6-12. PubMed ID: 11261299
    [No Abstract]   [Full Text] [Related]  

  • 2. [Regulation of cell cycle control in lung cancer].
    Wang Y; Toyoshima H
    Nihon Rinsho; 2002 May; 60 Suppl 5():89-93. PubMed ID: 12101780
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential expression of p16/p21/p27 and cyclin D1/D3, and their relationships to cell proliferation, apoptosis, and tumour progression in invasive ductal carcinoma of the breast.
    Wong SC; Chan JK; Lee KC; Hsiao WL
    J Pathol; 2001 May; 194(1):35-42. PubMed ID: 11329139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cyclin D1 high and cyclin E high subgroups of breast cancer: separate pathways in tumorogenesis based on pattern of genetic aberrations and inactivation of the pRb node.
    Lodén M; Stighall M; Nielsen NH; Roos G; Emdin SO; Ostlund H; Landberg G
    Oncogene; 2002 Jul; 21(30):4680-90. PubMed ID: 12096344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of cell cycle regulator molecules in surgically resected stage I and II breast cancer.
    Peters MG; Vidal Mdel C; Giménez L; Mauro L; Armanasco E; Cresta C; Bal de Kier Joffé E; Puricelli L
    Oncol Rep; 2004 Nov; 12(5):1143-50. PubMed ID: 15492807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of the potential suppressor gene IGFBP-rP1 in human breast cancer is associated with inactivation of the retinoblastoma protein, cyclin E overexpression and increased proliferation in estrogen receptor negative tumors.
    Landberg G; Ostlund H; Nielsen NH; Roos G; Emdin S; Burger AM; Seth A
    Oncogene; 2001 Jun; 20(27):3497-505. PubMed ID: 11429696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell division cycle alterations and human tumors.
    Della Ragione F; Borriello A; Della Pietra V; Cucciolla V; Oliva A; Barbarisi A; Iolascon A; Zappia V
    Adv Exp Med Biol; 1999; 472():73-88. PubMed ID: 10736618
    [No Abstract]   [Full Text] [Related]  

  • 8. Accommodating haploinsufficient tumor suppressor genes in Knudson's model.
    Cook WD; McCaw BJ
    Oncogene; 2000 Jul; 19(30):3434-8. PubMed ID: 10918600
    [No Abstract]   [Full Text] [Related]  

  • 9. Leptin-induced growth of human ZR-75-1 breast cancer cells is associated with up-regulation of cyclin D1 and c-Myc and down-regulation of tumor suppressor p53 and p21WAF1/CIP1.
    Chen C; Chang YC; Liu CL; Chang KJ; Guo IC
    Breast Cancer Res Treat; 2006 Jul; 98(2):121-32. PubMed ID: 16752079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-erbB2, p27 and G1/S aberrations in human primary breast cancer.
    Lodén M; Perris F; Nielsen NH; Emdin SO; Landberg G
    Anticancer Res; 2003; 23(3A):2053-61. PubMed ID: 12894578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic implication of cyclin E expression and its relationship with cyclin D1 and p27Kip1 expression on tissue microarrays of node negative breast cancer.
    Han S; Park K; Bae BN; Kim KH; Kim HJ; Kim YD; Kim HY
    J Surg Oncol; 2003 Aug; 83(4):241-7. PubMed ID: 12884237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cell cycle regulators as prognostic factors of breast cancers].
    Ohta T; Fukuda M
    Nihon Rinsho; 2000 Apr; 58 Suppl():448-53. PubMed ID: 11026032
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhanced expression of cyclin E and cyclin A in human hepatocellular carcinomas.
    Ohashi R; Gao C; Miyazaki M; Hamazaki K; Tsuji T; Inoue Y; Uemura T; Hirai R; Shimizu N; Namba M
    Anticancer Res; 2001; 21(1B):657-62. PubMed ID: 11299822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell cycle dysregulation influences survival in high risk breast cancer patients.
    Königsberg R; Rögelsperger O; Jäger W; Thalhammer T; Klimpfinger M; De Santis M; Hudec M; Dittrich C
    Cancer Invest; 2008 Aug; 26(7):734-40. PubMed ID: 18665474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer.
    Kamai T; Takagi K; Asami H; Ito Y; Oshima H; Yoshida KI
    Br J Cancer; 2001 May; 84(9):1242-51. PubMed ID: 11336477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of cell cycle regulators in phenotypic variants of transgenically induced bladder tumors: implications for tumor behavior.
    Garcia-España A; Salazar E; Sun TT; Wu XR; Pellicer A
    Cancer Res; 2005 Feb; 65(4):1150-7. PubMed ID: 15734997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer.
    Bali A; O'Brien PM; Edwards LS; Sutherland RL; Hacker NF; Henshall SM
    Clin Cancer Res; 2004 Aug; 10(15):5168-77. PubMed ID: 15297421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of cell cycle regulatory proteins in the pathogenesis of melanoma.
    Li W; Sanki A; Karim RZ; Thompson JF; Soon Lee C; Zhuang L; McCarthy SW; Scolyer RA
    Pathology; 2006 Aug; 38(4):287-301. PubMed ID: 16916716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in stage T1 grade 3 bladder cancer survival: the role of G1-S modulators (p53, p21Waf1, p27kip1, Cyclin D1, and Cyclin D3) and proliferation index (ki67-MIB1).
    Lopez-Beltran A; Luque RJ; Alvarez-Kindelan J; Quintero A; Merlo F; Carrasco JC; Requena MJ; Montironi R
    Eur Urol; 2004 May; 45(5):606-12. PubMed ID: 15082203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.